A Study to Test How Well Multiple Doses of BI 765423 Are Tolerated by Healthy Men

NCT06232252 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 765423
DRUG: Placebo matching BI 765423

Sponsor

Boehringer Ingelheim